Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Cognizant to acquire Belcan in $1.3bn deal to enhance engineering and digital services Cognizant Technology Solutions Corp. (NASDAQ: CTSH) has signed a definitive agreement to acquire Belcan, LLC, a leading provider… byPallavi MadhirajuJune 11, 2024